Brief Summary
Type:
Brain Tumors / Neurologic Cancers
Study Type:
Treatment
Phase:
II
ClinicalTrials.gov Identifier:
NCT03180502
Study #:
STUDY00150097
Start Date:
Jul 11, 2023
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT03180502
View Complete Trial Details & Eligibility at ClinicalTrials.gov
